Outlook Therapeutics Stock Price - OTLK

0.60
0.0101 (1.71%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Outlook Therapeutics Inc OTLK NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0101 1.71% 0.60 0.59 0.63 0.61 0.5899 10:33:55
Bid Price Ask Price Spread Spread % News
0.61 0.62 0.01 1.61% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
358 156,208 $ 0.5997534 $ 93,686 449,136 0.4011 - 4.6557
Last Trade Time Type Quantity Stock Price Currency
10:33:43 900 $ 0.60 USD

Outlook Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 51.56M 82.51M $ -30.09M -2.42 - 74.32M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 7.00 9.90%

more financials information »

Outlook Therapeutics News

Loading Messages....

Latest OTLK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OTLK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.58850.630.55990.5774644203,9810.01151.95%
1 Month0.640.680.4990.5752713365,175-0.04-6.25%
3 Months0.87831.120.4990.8198657474,200-0.2783-31.69%
6 Months1.361.740.40110.9317323658,523-0.76-55.88%
1 Year4.564.65570.40112.041,752,889-3.96-86.84%
3 Years5.6020.000.40112.271,368,046-5.00-89.29%
5 Years5.6020.000.40112.271,368,046-5.00-89.29%

Outlook Therapeutics Description

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.


Your Recent History
NASDAQ
OTLK
Outlook Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.